bf/AMEX:CLDI_icon.jpeg

COM:CALIDIBIO

Calidi Biotherapeutics

  • Stock

Last Close

2.15

22/11 21:00

Market Cap

37.48M

Beta: -

Volume Today

1.48M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
revenue
449K
-
45K
89.98%
cost of revenue
94K
-
274K
191.49%
1.26M
358.39%
gross profit
355K
-
-229K
164.51%
-1.26M
448.47%
selling and marketing expenses
-4.38M
-
-260K
94.07%
-1.26M
383.08%
general and administrative expenses
6.16M
-
15.90M
158.02%
15.98M
0.52%
selling general and administrative expenses
1.78M
-
15.64M
777.93%
14.73M
5.84%
research and development expenses
4.67M
-
7.26M
55.26%
13.01M
79.25%
other expenses
9K
-
-5K
155.56%
-51K
920.00%
cost and expenses
1.78M
-
23.17M
1,200.61%
28.99M
25.11%
operating expenses
1.78M
-
22.90M
1,185.23%
27.74M
21.12%
interest expense
614K
-
158K
74.27%
1.07M
576.58%
ebitda
-1.78M
-
-22.87M
1,183.49%
-27.74M
21.29%
operating income
-1.78M
-
-23.13M
1,198.09%
-28.99M
25.35%
depreciation and amortization
153K
-
260K
69.93%
1.26M
383.08%
total other income expenses net
5.17M
-
-2.29M
144.27%
-208K
90.91%
income before tax
3.39M
-
-25.42M
850.45%
-29.20M
14.89%
income tax expense
11K
-
11K
0%
16K
45.45%
net income
3.39M
-
-25.43M
850.78%
-29.22M
14.90%
weighted average shs out
2.88M
-
850.50K
70.42%
1.69M
98.55%
weighted average shs out dil
2.88M
-
850.50K
70.42%
1.69M
98.55%
eps
1.18
-
-29.90
2,633.90%
-17.30
42.14%
epsdiluted
1.18
-
-29.90
2,633.90%
-17.30
42.14%

All numbers in (except ratios and percentages)